Mechanistically, LNMAT1 epigenetically activates CCL2 expression and recruits macrophages into bladder cancer, which promotes lymphatic metastasis via VEGF-C excretion (Chen et al., 2018). The gene discussed is DUXAP9; the disease is urinary bladder carcinoma.